StockSelector.com
  Research, Select, & Monitor Wednesday, December 19, 2018 10:50:13 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Array BioPharma Inc.$15.48$.352.31%

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  Array BioPharma Inc. vs Medical Labs & Research

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. The company's proprietary drug development pipeline is focused on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas.




Most are providers of a broad range of diagnostic testing services to hospitals, patients, physicians, and managed care organizations. These can include magnetic-resonance imaging, gene mapping, hair sample testing, etc. Others in this category engage in contractual medical research to study the side effects of drugs about to come onto the market or conduct their own drug research.
 Totals Company Industry
  Sales: $173.8 Mil $21,202.3 Mil
  Market Cap: $3,210.5 Mil $42,305.5 Mil
  Analysts Recommendation: Strong Buy Buy

 Averages Company Industry
 Growth
  Historic Revenue: 15.2% (3.1%)
  Estimated Revenue: 12.0% 150.5%
  Historic Earnings: N/A 1.1%
  Estimated Earnings: N/A 15.1%
  Stock Price (1 Year): 40.1% (2.7%)
  Cash per Share: (26.1%) (1.2%)
  Dividend: N/A N/A
 Price
  Trailing PE: N/A N/A
  Forward PE: N/A 27.7
  Price-to-Sales: 16.0 N/A
  Price-to-Book: 14.5 5.6
  Dividend Yield: N/A N/A
  Market Cap: $3,210.5 Mil $4,230.5 Mil
  Operations
  Net Margin: (65.9%) (172.0%)
  Gross Margin: 65.8% 57.0%
  Return on Equity: (.7) (.1)
  Return on Assets: (.3) (.1)
  Balance Sheet
  Current Ratio: 4.7 3.0
  Quick Ratio: 4.7 3.0
  Cash Ratio: 4.3 2.3
  Debt-to-Equity: 1.1 .8
  Interest Coverage: (.4) (.1)
 Technicals
  Relative-Strength Index: 43.7 N/A

 Other companies in Medical Labs & Research Price Market Cap
  Laboratory Corp. of America Holdings  (LH) $130.48 $13,400.3 Mil
  Quest Diagnostics, Inc.  (DGX) $83.62 $11,623.2 Mil
  Tableau Software  (DATA) $121.59 $10,124.1 Mil
  CyberArk  (CYBR) $71.21 $2,668.7 Mil
  SP Plus Corporation  (SP) $28.12 $636.3 Mil






Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.